Cargando…
Quinolones Modulate Ghrelin Receptor Signaling: Potential for a Novel Small Molecule Scaffold in the Treatment of Cachexia
Cachexia is a metabolic wasting disorder characterized by progressive weight loss, muscle atrophy, fatigue, weakness, and appetite loss. Cachexia is associated with almost all major chronic illnesses including cancer, heart failure, obstructive pulmonary disease, and kidney disease and significantly...
Autores principales: | Torres-Fuentes, Cristina, Pastor-Cavada, Elena, Cano, Rafael, Kandil, Dalia, Shanahan, Rachel, Juan, Rocio, Shaban, Hamdy, McGlacken, Gerard P., Schellekens, Harriët |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032407/ https://www.ncbi.nlm.nih.gov/pubmed/29848961 http://dx.doi.org/10.3390/ijms19061605 |
Ejemplares similares
-
A Novel Non-Peptidic Agonist of the Ghrelin Receptor with Orexigenic Activity In vivo
por: Pastor-Cavada, Elena, et al.
Publicado: (2016) -
Ghrelin for cachexia
por: Akamizu, Takashi, et al.
Publicado: (2010) -
Direct arylation and heterogeneous catalysis; ever the twain shall meet
por: Cano, Rafael, et al.
Publicado: (2015) -
Chronic Renal Failure, Cachexia, and Ghrelin
por: Laviano, A., et al.
Publicado: (2010) -
Novel mechanism of ghrelin therapy for cachexia
por: Hatanaka, Michiyoshi, et al.
Publicado: (2015)